Walleye Capital LLC Neogenomics Inc Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Walleye Capital LLC holds 22,300 shares of NEO stock, worth $329,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,300

Holding current value

$329,371

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $151,822 - $200,880	11,330 New	11,330 $167,000
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $326,980 - $480,379	26,912 New	26,912 $331,000
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $16,957 - $31,732	2,629 New	2,629 $24,000
Q2 2022 Aug 08, 2022	SELL	$7.06 - $13.97 $714,923 - $1.41 Million	-101,264 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $1.23 Million - $3.57 Million	101,264 New	101,264 $1.23 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $94,800 - $149,200	-5,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $84,128 - $115,456	4,400 Added 733.33%	5,000 $96,000
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $11,742 - $14,460	600 New	600 $13,000

Others Institutions Holding NEO

# of Institutions

292

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$291 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$207 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$102 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$97.5 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$96.6 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.86B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account